This company develops a topical treatment using targeted nanoparticles to eliminate p16-expressing keratinocytes, addressing aging-related skin conditions. Their technology aims to treat conditions like actinic keratosis and UV-damaged skin by selectively removing problematic cells.
Funding
Funding not disclosed
Founders
Product
Problem
As skin ages, cells can develop age-related changes that contribute to "inflammaging," leading to visible signs of aging. Current cosmetic treatments often lack the ability to selectively target and address these problematic cells.
Solution
Ponce Aurora, affiliated with SENOTHERAPEUTIX, Inc., is developing Yuuth™, a cosmetic product designed to reverse signs of aging by targeting cells that cause "inflammaging." Yuuth™ utilizes MitoXcel™ technology to eliminate or neutralize these cells in the skin and throughout the body, while also re-energizing and rejuvenating aging cells. This dual-action approach aims to restore youthful balance. Yuuth™ is FDA-regulated as a cosmetic and certified as never having been tested on animals.
Target Audience
The primary target audience is individuals seeking to reduce visible signs of aging and improve skin health through cosmetic interventions.
Features
- Utilizes MitoXcel™ technology to target and eliminate cells contributing to "inflammaging."
- Aims to re-energize and rejuvenate remaining aging cells.
- Topical application for cosmetic use.
- FDA-regulated as a cosmetic.
- Certified as never tested on animals.